Related Experiment Video
Updated: Aug 2, 2025
Biomimetic Materials to Characterize Bacteria-host Interactions
Published on: November 16, 2015
Synthesis, characterization, and antibacterial activities of a heteroscorpionate derivative platinum complex against
Syong H Nam-Cha1, Elena Domínguez-Jurado2,3, Selena L Tinoco-Valencia4
1Department of Pathology, Complejo Hospitalario Universitario, Albacete, Spain.
Abstract:
Staphylococcus aureus is one of the species with the greatest clinical importance and greatest impact on public health. In fact, methicillin-resistant S. aureus (MRSA) is considered a pandemic pathogen, being essential to develop effective medicines and combat its rapid spread. This study aimed to foster the translation of clinical research outcomes based on metallodrugs into clinical practice for the treatment of MRSA. Bearing in mind the promising anti-Gram-positive effect of the heteroscorpionate ligand 1,1'-(2-(4-isopropylphenyl)ethane-1,1-diyl)bis(3,5-dimethyl-1H-pyrazole) (2P), we propose the coordination of this compound to platinum as a clinical strategy with the ultimate aim of overcoming resistance in the treatment of MRSA. Therefore, the novel metallodrug 2P-Pt were synthetized, fully characterized and its antibacterial effect against the planktonic and biofilm state of S. aureus evaluated. In this sense, three different strains of S. aureus were studied, one collection strain of S. aureus sensitive to methicillin and two clinical MRSA strains. To appraise the antibacterial activity, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), minimum biofilm inhibitory concentration (MBIC), and minimum biofilm eradication concentration (MBEC) were determined. Moreover, successful outcomes on the development of biofilm in a wound-like medium were obtained. The mechanism of action for 2P-Pt was proposed by measuring the MIC and MBC with EDTA (cation mediated mechanism) and DMSO (exogenous oxidative stress mechanism). Moreover, to shed light on the plausible antistaphylococcal mechanism of this novel platinum agent, additional experiments using transmission electron microscopy were carried out. 2P-Pt inhibited the growth and eradicated the three strains evaluated in the planktonic state. Another point worth stressing is the inhibition in the growth of MRSA biofilm even in a wounded medium. The results of this work support this novel agent as a promising therapeutic alternative for preventing infections caused by MRSA.
Insights
A novel platinum-based metallodrug, 2P-Pt, effectively inhibits and eradicates both planktonic and biofilm forms of methicillin-resistant Staphylococcus aureus (MRSA). This compound shows promise as a new therapeutic strategy against challenging MRSA infections.
Area of Science:
- Medicinal Chemistry
- Antimicrobial Research
- Metallodrug Development
Background:
- Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA), poses a significant global health threat due to widespread resistance.
- Developing novel therapeutic agents is crucial to combat the increasing prevalence and resistance of MRSA infections.
- Metallodrugs offer a promising avenue for novel antimicrobial strategies, potentially overcoming existing resistance mechanisms.
Purpose of the Study:
- To synthesize and characterize a novel platinum-based metallodrug, 2P-Pt, for potential MRSA treatment.
- To evaluate the antibacterial efficacy of 2P-Pt against planktonic and biofilm states of S. aureus, including MRSA strains.
- To investigate the mechanism of action of 2P-Pt against S. aureus.
Main Methods:
- Synthesis and full characterization of the novel metallodrug 2P-Pt.
- Determination of Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC), Minimum Biofilm Inhibitory Concentration (MBIC), and Minimum Biofilm Eradication Concentration (MBEC) for S. aureus strains.
- Evaluation of biofilm formation in a wound-like medium and mechanistic studies using EDTA, DMSO, and transmission electron microscopy.
Main Results:
- The novel metallodrug 2P-Pt demonstrated potent antibacterial activity, inhibiting and eradicating all tested strains of S. aureus, including MRSA, in planktonic form.
- 2P-Pt effectively inhibited the growth of MRSA biofilms, even under conditions mimicking wound environments.
- Mechanistic studies suggested a cation-mediated and exogenous oxidative stress mechanism for 2P-Pt's antibacterial action.
Conclusions:
- The novel platinum-based metallodrug 2P-Pt is a promising therapeutic candidate for combating MRSA infections.
- 2P-Pt exhibits significant efficacy against both planktonic and biofilm forms of MRSA, offering a potential strategy to overcome resistance.
- Further research into 2P-Pt could lead to the development of effective treatments for challenging staphylococcal infections.
